Drug intelligence / Profile preview

bovine whey immunoglobulin-rich fraction

Development stage
Unknown
Lead developer
Griffith University
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Bovine whey immunoglobulin-rich fraction is a biologic nutraceutical derived from cow's milk whey, enriched with immunoglobulins (primarily IgG). It is designed for oral administration to modulate the immune system via the gut-skin axis. In a pilot clinical study conducted by Griffith University, this fraction was evaluated in combination with Glycomax lactoferrin for the treatment of atopic dermatitis. The study, published in the *Journal of Dermatological Science* in 2017, reported significant improvements in SCORAD and DLQI scores, suggesting its potential as a therapeutic supplement for managing inflammatory skin conditions by influencing intestinal immunity and systemic inflammation.

Other names
Ig-rich fractionbovine whey-derived immunoglobulin-rich fraction
02

Targets

HSPG (Basement membrane-specific heparan sulfate proteoglycan core protein (perlecan))

Beyond the preview

Go deeper on bovine whey immunoglobulin-rich fraction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bovine whey immunoglobulin-rich fraction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call